In contrast, among dMMR/MSI colorectal cancers, the GALNT7-Low subset exhibits high levels of tumor cell PD-L1 and poor prognosis, highlighting the need for more intensive therapeutic strategies beyond current clinical practice. Here, GALNT7 is linked to neoplasm.